{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:32:20Z","timestamp":1697326340312},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1993,9,1]],"date-time":"1993-09-01T00:00:00Z","timestamp":746841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[1993,9]]},"DOI":"10.1007\/bf02231591","type":"journal-article","created":{"date-parts":[[2005,10,20]],"date-time":"2005-10-20T23:02:07Z","timestamp":1129849327000},"page":"415-417","source":"Crossref","is-referenced-by-count":9,"title":["Hypothyroidism and arthritis during interferon therapy"],"prefix":"10.1007","volume":"12","author":[{"given":"L.","family":"D'Hondt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Delannoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Docquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02231591_CR1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1200\/JCO.1986.4.2.234","volume":"4","author":"J.R. Quesada","year":"1986","unstructured":"Quesada, J.R., Talpaz, M., Rios, A., Kurzrock, R., Gutterman, J. Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 1986, 4, 234\u2013243.","journal-title":"J Clin Oncol"},{"key":"BF02231591_CR2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(85)92475-4","volume":"1","author":"J.S. Fentiman","year":"1985","unstructured":"Fentiman, J.S., Thomas, B.S., Balkwill, F.R., Rubens, R.D., Hayward, J.L. Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet 1985, 1, 1166.","journal-title":"Lancet"},{"key":"BF02231591_CR3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.7326\/0003-4819-105-2-306_1","volume":"105","author":"L.P. Akard","year":"1986","unstructured":"Akard, L.P., Hoffman, R., Elias, L., Saiers, J.H. Alpha-interferon and immune hemolytic anemia. Ann Intern Med 1986, 105, 306.","journal-title":"Ann Intern Med"},{"key":"BF02231591_CR4","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1001\/jama.1986.03370140076016","volume":"255","author":"E.A. Abdi","year":"1986","unstructured":"Abdi, E.A., Venner, P.M. Immune thrombocytopenia after alpha-interferon therapy in patients with cancer. JAMA 1986, 255, 1878\u20131879.","journal-title":"JAMA"},{"key":"BF02231591_CR5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ajh.2830190411","volume":"19","author":"K.F. Mangan","year":"1985","unstructured":"Mangan, K.F., Zidar, B., Shadduck, R.K., Zeigler, Z., Winkelstein, A. Interferon-induced aplasia: Evidence for T-cell mediated suppression of hematopoiesis and recovery after treatment with horse antihuman thymocyte globulin. Am J Hematol 1985, 19, 401\u2013413.","journal-title":"Am J Hematol"},{"key":"BF02231591_CR6","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO;2-5","volume":"65","author":"K.C. Conlon","year":"1990","unstructured":"Conlon, K.C., Urba, W.J., Smith, J.W., Steis, R.G., Longo, D.L., Clark, J.W. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990, 65, 2237\u20132242.","journal-title":"Cancer"},{"key":"BF02231591_CR7","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/1097-0142(19911001)68:7<1536::AID-CNCR2820680713>3.0.CO;2-B","volume":"68","author":"P.J. Schilling","year":"1991","unstructured":"Schilling, P.J., Kurzrock, R., Kantarjian, H., Gutterman, J.U., Talpaz, M. Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 1991, 68, 1536\u20131537.","journal-title":"Cancer"},{"key":"BF02231591_CR8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-115-3-178","volume":"115","author":"L.E. R\u00f6nnblom","year":"1991","unstructured":"R\u00f6nnblom, L.E., Gunnar, V.A., Kjell, E.O. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991, 115, 178\u2013183.","journal-title":"Ann Intern Med"},{"key":"BF02231591_CR9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-116-5-427_1","volume":"116","author":"P. Chazerain","year":"1992","unstructured":"Chazerain, P., Meyer, O., Kahn, M.F. Rheumatoid arthritis-like disease after alpha-interferon therapy. Ann Intern Med 1992, 116, 427.","journal-title":"Ann Intern Med"},{"key":"BF02231591_CR10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.7326\/0003-4819-117-3-266_2","volume":"117","author":"Y. Ueno","year":"1992","unstructured":"Ueno, Y., Sohma, T. Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma. Ann Intern Med 1992, 117, 266\u2013267.","journal-title":"Ann Intern Med"},{"key":"BF02231591_CR11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF02206672","volume":"10","author":"S. Maccari","year":"1991","unstructured":"Maccari, S., Bassi, C., Giovannini, A.G., Plancher, A.C. A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy. Clin Rheumatol 1991, 10, 452\u2013454.","journal-title":"Clin Rheumatol"},{"key":"BF02231591_CR12","unstructured":"Wandl, U.B., Nagel-Hiemke, M., May, D., Kreuzfelder, E., Kloke, O., Moritz, T., Kranzhoff, M., Anders, C., Seeber, S., Niederle, N. Antinuclear antibodies before and during interferon treatment in patients with myeloproliferative disease. Blood 1991, 10, 31a."},{"key":"BF02231591_CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840100106","volume":"10","author":"W.J. Mayet","year":"1989","unstructured":"Mayet, W.J., Hess, G., Gerken, G., Rossol, S., Voth, R., Mann, M., Meyer zum Buschenfelde K.H. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 1989, 10, 24\u201328.","journal-title":"Hepatology"},{"key":"BF02231591_CR14","unstructured":"Kluin-Nelemans, J.F., van den Burgh, J.F., Louwagie, A., Delannoy, A., Boogaerts, M.A., Bosly, A., Michaux, J.L., van den Berghe, H., Hagemeijer, A. Interferon alpha therapy for CML: preliminary report of a large multicenter randomized study. Data presented at 2nd International Conference on Chronic Myeloid Leukemia, Bologna, Italy, October, 1992 (abstr 97)."}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02231591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02231591\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02231591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T18:54:45Z","timestamp":1557860085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02231591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,9]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,9]]}},"alternative-id":["BF02231591"],"URL":"https:\/\/doi.org\/10.1007\/bf02231591","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,9]]}}}